Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Enanta Pharmaceuticals)"
Count: 39
Selected: 0
NCT IDTitle
NCT04498741Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
NCT04470388A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment
NCT04008004A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)
NCT03755778Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
NCT03750383Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects
NCT03384823A Study of EDP-938 in Healthy Subjects
NCT02918929A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD
NCT03394924A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
NCT05616728A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19
NCT05594615Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects
NCT05594602Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.
NCT05587478A Study of EDP-323 in Healthy Subjects
NCT05568706A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.
NCT05246878A Study of EDP-235 in Healthy Subjects
NCT04971512A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
NCT04927793Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects
NCT04871724Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects
NCT04816721A Study to Evaluate EDP 938 Regimens in Children With RSV
NCT04783753Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects
NCT04633187Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract
NCT04559126A Study of EDP-297 in Healthy Subjects
NCT04378010A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH
NCT04196101A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
NCT03783897A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects
NCT03748628Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects
NCT03691623A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model
NCT03610945Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers
NCT03421431A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
NCT03213145Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
NCT03207425A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
NCT03187496Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.
NCT02652377EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients
NCT02255968Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788
NCT02173574Two-way Interaction Between Alisporivir and EDP239
NCT01999725Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788
NCT01856426Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects
NCT00990145Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers
NCT00989872Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers
NCT00270517Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia